Literature DB >> 11544265

The experimental use of antisense oligonucleotides: a guide for the perplexed.

C A Stein1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11544265      PMCID： PMC209389          DOI： 10.1172/JCI13885

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  24 in total

1.  RNase H cleavage of RNA hybridized to oligonucleotides containing methylphosphonate, phosphorothioate and phosphodiester bonds.

Authors:  P J Furdon; Z Dominski; R Kole
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

2.  Role of RNase H in hybrid-arrested translation by antisense oligonucleotides.

Authors:  R Y Walder; J A Walder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

3.  CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.

Authors:  D M Klinman; A K Yi; S L Beaucage; J Conover; A M Krieg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

4.  Enzymatic amplification of translation inhibition of rabbit beta-globin mRNA mediated by anti-messenger oligodeoxynucleotides covalently linked to intercalating agents.

Authors:  C Cazenave; N Loreau; N T Thuong; J J Toulmé; C Hélène
Journal:  Nucleic Acids Res       Date:  1987-06-25       Impact factor: 16.971

5.  Tetranucleotide GGGA motif in primary RNA transcripts. Novel target site for antisense design.

Authors:  G C Tu; Q N Cao; F Zhou; Y Israel
Journal:  J Biol Chem       Date:  1998-09-25       Impact factor: 5.157

6.  Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.

Authors:  Z K Ballas; W L Rasmussen; A M Krieg
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

7.  Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity.

Authors:  I Lebedeva; R Rando; J Ojwang; P Cossum; C A Stein
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

8.  Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase.

Authors:  B P Monia; J F Johnston; T Geiger; M Muller; D Fabbro
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

9.  Inhibition of high affinity basic fibroblast growth factor binding by oligonucleotides.

Authors:  S M Fennewald; R F Rando
Journal:  J Biol Chem       Date:  1995-09-15       Impact factor: 5.157

10.  Physicochemical properties of phosphorothioate oligodeoxynucleotides.

Authors:  C A Stein; C Subasinghe; K Shinozuka; J S Cohen
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971
View more
  35 in total

1.  Identification of gene function and functional pathways by systemic plasmid-based ribozyme targeting in adult mice.

Authors:  Mohammed Kashani-Sabet; Yong Liu; Sylvia Fong; Pierre-Yves Desprez; Shuqing Liu; Guanghuan Tu; Mehdi Nosrati; Chakkrapong Handumrongkul; Denny Liggitt; Ann D Thor; Robert J Debs
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

2.  A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain.

Authors:  Mahesh M Thakkar; Stuart Winston; Robert W McCarley
Journal:  J Neurosci       Date:  2003-05-15       Impact factor: 6.167

3.  miR-221 silencing blocks hepatocellular carcinoma and promotes survival.

Authors:  Jong-Kook Park; Takayuki Kogure; Gerard J Nuovo; Jinmai Jiang; Lei He; Ji Hye Kim; Mitch A Phelps; Tracey L Papenfuss; Carlo M Croce; Tushar Patel; Thomas D Schmittgen
Journal:  Cancer Res       Date:  2011-10-18       Impact factor: 12.701

4.  The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor.

Authors:  Paolo Ciana; Marta Fumagalli; Maria Letizia Trincavelli; Claudia Verderio; Patrizia Rosa; Davide Lecca; Silvia Ferrario; Chiara Parravicini; Valérie Capra; Paolo Gelosa; Uliano Guerrini; Silvia Belcredito; Mauro Cimino; Luigi Sironi; Elena Tremoli; G Enrico Rovati; Claudia Martini; Maria P Abbracchio
Journal:  EMBO J       Date:  2006-09-21       Impact factor: 11.598

Review 5.  Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.

Authors:  Paula J Bates; Damian A Laber; Donald M Miller; Shelia D Thomas; John O Trent
Journal:  Exp Mol Pathol       Date:  2009-01-20       Impact factor: 3.362

6.  Essential role of ADAM28 in regulating the proliferation and differentiation of human dental papilla mesenchymal cells (hDPMCs).

Authors:  Zheng Zhao; Liang Tang; Zhihong Deng; Lingying Wen; Yan Jin
Journal:  Histochem Cell Biol       Date:  2008-08-09       Impact factor: 4.304

Review 7.  Targeting long non-coding RNA to therapeutically upregulate gene expression.

Authors:  Claes Wahlestedt
Journal:  Nat Rev Drug Discov       Date:  2013-06       Impact factor: 84.694

Review 8.  Managing the sequence-specificity of antisense oligonucleotides in drug discovery.

Authors:  Peter H Hagedorn; Bo R Hansen; Troels Koch; Morten Lindow
Journal:  Nucleic Acids Res       Date:  2017-03-17       Impact factor: 16.971

Review 9.  Non-coding RNAs as drug targets.

Authors:  Masayuki Matsui; David R Corey
Journal:  Nat Rev Drug Discov       Date:  2016-07-22       Impact factor: 84.694

10.  A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.

Authors:  Li Lin; Brian Hutzen; Pui-Kai Li; Sarah Ball; Mingxin Zuo; Stephanie DeAngelis; Elizabeth Foust; Matthew Sobo; Lauren Friedman; Deepak Bhasin; Ling Cen; Chenglong Li; Jiayuh Lin
Journal:  Neoplasia       Date:  2010-01       Impact factor: 5.715
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.